Sabby Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-486	Closed	-$7.28M	–	182
2017 Q4	$7.28M	Sell	486 -771	-61%	-$114K	0.66%	29
2017 Q3	$19.1M	Buy	1,257 +446	+55%	+$67.1K	1.25%	16
2017 Q2	$10.5M	Buy	811 +269	+50%	+$32.4K	0.68%	23
2017 Q1	$5.93M	Buy	542 +246	+83%	+$21.7K	0.32%	43
2016 Q4	$2.18M	Buy	296 +36	+14%	+$2.93K	0.13%	95
2016 Q3	$2.27M	Hold	260	–	–	0.08%	119
2016 Q2	$2.24M	Buy	260 +227	+688%	+$19.6K	0.12%	102
2016 Q1	$262K	Buy	+33	New	+$2.98K	0.01%	247
2015 Q1	–	Sell	-9,592	Closed	-$114K	–	326
2014 Q4	$114K	Hold	9,592	–	–	3.6%	7
2014 Q3	$108K	Sell	9,592 -374	-4%	-$35.6K	4.14%	6
2014 Q2	$94.4M	Buy	9,966 +4,040	+68%	+$283K	4.05%	4
2014 Q1	$41.9M	Sell	5,926 -3,842	-39%	-$304K	2.35%	9
2013 Q4	$72.6M	Buy	9,768 +3,217	+49%	+$224K	4.63%	4
2013 Q3	$49.7M	Buy	6,551 +1,294	+25%	+$103K	3.23%	8
2013 Q2	$42M	Buy	+5,257	New	+$387K	2.8%	9